BACKGROUND: Myxomas are rare cardiac tumors which often present with stroke caused by tumorous or thrombotic emboli. Treatment with intravenous recombinant tissue plasminogen activator (rtPA) and intra-arterial thrombolysis has been described previously but mechanical thrombectomy has not yet been reported, and treatment of myxoma-related ischemic stroke remains a clinical and technical challenge. METHODS: Two patients with ischemic stroke due to cardiac myxoma in which mechanical thrombectomy was performed are presented. RESULTS: Endovascular thrombectomy after intravenous rtPA (bridging therapy) was safely achieved in both cases, although with different clinical outcomes and degrees of recanalization. CONCLUSIONS: In stroke secondary to cardiac myxoma, mechanical thrombectomy might represent a safe and effective treatment option. The authors suggest the use of histological examination of the clot for diagnosis as its composition may explain the differences in treatment outcome.
BACKGROUND:Myxomas are rare cardiac tumors which often present with stroke caused by tumorous or thrombotic emboli. Treatment with intravenous recombinant tissue plasminogen activator (rtPA) and intra-arterial thrombolysis has been described previously but mechanical thrombectomy has not yet been reported, and treatment of myxoma-related ischemic stroke remains a clinical and technical challenge. METHODS: Two patients with ischemic stroke due to cardiac myxoma in which mechanical thrombectomy was performed are presented. RESULTS: Endovascular thrombectomy after intravenous rtPA (bridging therapy) was safely achieved in both cases, although with different clinical outcomes and degrees of recanalization. CONCLUSIONS: In stroke secondary to cardiac myxoma, mechanical thrombectomy might represent a safe and effective treatment option. The authors suggest the use of histological examination of the clot for diagnosis as its composition may explain the differences in treatment outcome.
Authors: Javier Tejada; Alberto Galiana; Oscar Balboa; Belén Clavera; Laura Redondo-Robles; Nieves Alonso; Víctor Magadán Journal: BMJ Case Rep Date: 2013-09-02
Authors: Hong Xu; Sara Garcia-Ptacek; Marco Trevisan; Marie Evans; Bengt Lindholm; Maria Eriksdotter; Juan Jesus Carrero Pharm Journal: Neurology Date: 2021-05-05 Impact factor: 9.910